Fsd Pharma Inc Cl B (FSDDF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSDDF | ABT | SYK | BSX | MDT |
| Company | Fsd Pharma Inc Cl B | Abbott Laboratories | Stryker Corp | Boston Scientific Corp | Medtronic Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NYSE | NYSE |
| Open | 11.3669 | 117.10 | 389.49 | 90.00 | 86.51 |
| High | 11.3669 | 117.44 | 391.90 | 90.79 | 86.53 |
| Low | 8.2500 | 116.07 | 386.46 | 89.62 | 85.47 |
| Last | 9.0912 | 116.29 | 390.97 | 90.47 | 85.71 |
| Change | -1.7674 | -0.52 | +1.34 | +0.04 | -0.83 |
| % Change | -16.28% | -0.45% | +0.34% | +0.04% | -0.96% |
| Volume | 18,300 | 4,794,800 | 923,800 | 3,192,000 | 4,979,400 |
| 20-Day Average Volume | 7,450 | 5,008,035 | 1,371,505 | 5,387,280 | 7,052,965 |
| Previous Close | 10.8586 | 116.81 | 389.63 | 90.43 | 86.54 |
| Industry | Medical Products | Medical Products | Medical Products | Medical Products | Medical Products |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.7142 | 116.93 | 384.33 | 89.09 | 86.89 |
| 20-Day Raw Stochastic | 69.42% | 28.31% | 79.43% | 81.28% | 25.47% |
| 20-Day Relative Strength | 63.11% | 50.00% | 62.00% | 61.27% | 43.15% |
| Weighted Alpha | -79.66 | +10.92 | +33.96 | +60.21 | +6.25 |
| Today's Opinion | 40% Sell | 88% Buy | 100% Buy | 100% Buy | 24% Buy |
| Previous Opinion | 24% Sell | 88% Buy | 100% Buy | 100% Buy | 24% Buy |
| Last Month's Opinion | 100% Sell | 88% Buy | 72% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +67.47% since 12/31/19 | -1.56% since 11/25/24 | +1.57% since 11/25/24 | +1.37% since 11/25/24 | -0.05% since 11/25/24 |
| Low | 5.5381 on 01/02/20 | 116.07 on 12/03/24 | 384.91 on 11/26/24 | 89.10 on 11/26/24 | 85.02 on 11/26/24 |
| High | 11.3669 on 01/08/20 | 120.53 on 11/27/24 | 394.14 on 12/02/24 | 91.34 on 12/02/24 | 86.90 on 11/27/24 |
| 1-Month | |||||
| %Chg | +85.92% since 12/06/19 | -1.95% since 11/01/24 | +6.49% since 11/01/24 | +8.19% since 11/01/24 | -4.84% since 11/01/24 |
| Low | 3.9260 on 12/12/19 | 114.43 on 11/15/24 | 363.05 on 11/05/24 | 83.55 on 11/04/24 | 83.55 on 11/20/24 |
| High | 11.3669 on 01/08/20 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.93 on 11/22/24 | 92.03 on 11/06/24 |
| 3-Month | |||||
| %Chg | -21.06% since 10/08/19 | +1.42% since 09/03/24 | +8.72% since 09/03/24 | +11.50% since 09/03/24 | -3.65% since 09/03/24 |
| Low | 3.4312 on 10/23/19 | 111.68 on 10/04/24 | 343.95 on 10/07/24 | 80.50 on 09/05/24 | 83.55 on 11/20/24 |
| High | 12.2007 on 10/09/19 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.93 on 11/22/24 | 92.68 on 10/24/24 |
| 6-Month | |||||
| %Chg | -60.64% since 07/08/19 | +13.05% since 06/03/24 | +15.20% since 06/03/24 | +19.83% since 06/03/24 | +4.37% since 06/03/24 |
| Low | 3.4312 on 10/23/19 | 99.71 on 07/18/24 | 314.93 on 08/05/24 | 71.88 on 08/05/24 | 75.96 on 07/09/24 |
| High | 32.0595 on 08/14/19 | 121.00 on 11/06/24 | 398.20 on 11/18/24 | 91.93 on 11/22/24 | 92.68 on 10/24/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 68,911 | 201,699,760 | 149,044,016 | 133,337,128 | 109,904,728 |
| Shares Outstanding, K | 7,580 | 1,734,455 | 381,216 | 1,473,827 | 1,282,286 |
| Annual Sales | 70,000 | 40,109,000,000 | 20,498,000,000 | 14,240,000,000 | 32,364,000,000 |
| Annual Net Income | -17,520,000 | 5,723,000,000 | 3,165,000,000 | 1,591,000,000 | 3,677,000,000 |
| Last Quarter Sales | 10,000 | 10,635,000,000 | 5,494,000,000 | 4,209,000,000 | 8,403,000,000 |
| Last Quarter Net Income | -12,610,000 | 1,646,000,000 | 834,000,000 | 468,000,000 | 1,269,000,000 |
| 60-Month Beta | N/A | 0.73 | 0.94 | 0.80 | 0.82 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.21 on 10/16/24 | 2.87 on 10/29/24 | 0.63 on 10/23/24 | 1.26 on 11/19/24 |
| Latest Earnings Date | N/A | 01/22/25 | 10/29/24 | 10/23/24 | 11/19/24 |
| Most Recent Dividend | N/A | 0.550 on 10/15/24 | 0.800 on 09/30/24 | N/A | 0.700 on 09/27/24 |
| Next Ex-Dividends Date | N/A | 10/15/24 | 09/30/24 | N/A | 09/27/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.84 | 33.47 | 38.32 | 16.48 |